Cargando…

Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia

Hypersplenism and thrombocytopenia are common complications of liver cirrhosis or thalassemia, but current treatment strategies are limited. This study aimed to evaluate the efficacy and safety of thalidomide in the treatment of hypersplenism and thrombocytopenia in patients with liver cirrhosis or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yaocheng, Cai, Ning, Lai, Yongrong, Xu, Weiwei, Li, Jinyan, Huang, Lan, Huang, Ying, Hu, Meiling, Yang, Huangju, Chen, Jiangming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394185/ https://www.ncbi.nlm.nih.gov/pubmed/32792958 http://dx.doi.org/10.3389/fphar.2020.01137

Ejemplares similares

Investigating the Efficacy and Safety of Thalidomide for Treating Patients With ß-Thalassemia: A Meta-Analysis
por: Lu, Yanfei, et al.
Publicado: (2022)

Magnetic Resonance Imaging Quantification of the Liver Iron Burden and Volume Changes Following Treatment With Thalidomide in Patients With Transfusion-Dependent ß-Thalassemia
por: Che, Jinlian, et al.
Publicado: (2022)

Efficacy of Thalidomide Treatment in Children With Transfusion Dependent β-Thalassemia: A Retrospective Clinical Study
por: Li, Xinyu, et al.
Publicado: (2021)

Effects of thrombopoietin pre-treatment on peri-liver transplantation thrombocytopenia in a mouse model of cirrhosis with hypersplenism
por: Liu, Zi-Rong, et al.
Publicado: (2023)

Hypersplenism in Liver Cirrhosis: Is Conservative Treatment Still Best?
por: Tarazov, Pavel G., et al.
Publicado: (1995)

Percutaneous Microwave Ablation in the Spleen for Treatment of Hypersplenism in Cirrhosis Patients
por: Jiang, XiangWu, et al.
Publicado: (2015)

Safety and efficacy of thalidomide in patients with transfusion-dependent β-thalassemia: a randomized clinical trial
por: Chen, Jiang-Ming, et al.
Publicado: (2021)

Laparoscopic splenic artery ligation for hypersplenism in cirrhosis: A case series
por: Nag, Hirdaya H., et al.
Publicado: (2016)

Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria
por: Araten, David J, et al.
Publicado: (2014)

Laparoscopic Splenectomy in Colorectal Cancer Patients with Chemotherapy-Associated Thrombocytopenia due to Hypersplenism
por: Litvak, David A., et al.
Publicado: (2012)

Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis
por: Bucsics, Theresa, et al.
Publicado: (2022)

Hypersplenism: History and current status
por: Lv, Yunfu, et al.
Publicado: (2016)

Thalidomide for Patients with β-Thalassemia: A Multicenter Experience
por: Yang, Kun, et al.
Publicado: (2020)

Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
por: Ansari, Saqib H., et al.
Publicado: (2022)

Anaesthetic management of beta thalassemia major with hypersplenism for splenectomy in pediatric age group: Report of four cases
por: Jyothi, B., et al.
Publicado: (2015)

Spontaneous iliopsoas hematoma in a trasfusion dependent β-thalassemia patient with hypersplenism: a case report
por: Aishwariya, Padmakumari, et al.
Publicado: (2019)

Radiotherapy for hypersplenism from congestive splenomegaly
por: Liu, Mu-Tai, et al.
Publicado: (2004)

Hypersplenic Anæmia relieved by Splenectomy
por: Nelson, M. G.
Publicado: (1950)

Simultaneous partial splenectomy during liver transplantation for advanced cirrhosis patients combined with severe splenomegaly and hypersplenism
por: Jiang, Wen-Tao, et al.
Publicado: (2021)

Thalidomide Prevented and Ameliorated Pathogenesis of Crohn’s Disease in Mice via Regulation of Inflammatory Response and Fibrosis
por: Chen, Hongjin, et al.
Publicado: (2019)

Does the Warren Shunt Correct Hypersplenism?
por: Lodge, J. Peter A., et al.
Publicado: (1990)

Challenges in transfusion and the role of Thalidomide in E‐β‐Thalassemia—A case report
por: Javed, Rizwan, et al.
Publicado: (2020)

Thalidomide-Induced Primary Amenorrhea in a Patient With HbE/Beta-Thalassemia
por: Singha, Arijit, et al.
Publicado: (2023)

Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis
por: Lv, Peng, et al.
Publicado: (2006)

Imbalance of erythropoiesis and iron metabolism in patients with thalassemia
por: Huang, Yumei, et al.
Publicado: (2019)

Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment
por: Li, Bi, et al.
Publicado: (2023)

Splenic artery embolization with detachable balloons for hypersplenism
por: Pang, Xiaoxi, et al.
Publicado: (2018)

Splenomegaly and hypersplenism in hepatic vena cava syndrome
por: Man Shrestha, Santosh
Publicado: (2021)

A Phase Ib Study of the Simmitecan Single Agent and in Combination With 5-Fluorouracil/Leucovorin or Thalidomide in Patients With Advanced Solid Tumor
por: Zhang, Qi, et al.
Publicado: (2022)

Splenectomy before hepatectomy for patients with hepatocellular carcinoma and hypersplenism: A retrospective study
por: Zhou, Chenyang, et al.
Publicado: (2021)

Administration of recombinant human thrombopoietin is associated with alleviated thrombocytopenia in adult intensive care unit patients with pneumonia: A single-center retrospective study
por: Chen, Bailiang, et al.
Publicado: (2022)

Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism
por: Zhang, Er-Lei, et al.
Publicado: (2023)

Atraumatic splenic rupture was attributed to intra-cystic haemorrhage and hypersplenism in a patient with cirrhosis and portal hypertension: A case report
por: Li, Hao, et al.
Publicado: (2020)

Tirofiban-induced thrombocytopenia
por: Wang, Jun, et al.
Publicado: (2023)

Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis
por: Huang, Yumei, et al.
Publicado: (2019)

Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial
por: Sun, Xin, et al.
Publicado: (2021)

Splenectomy for hypersplenism with or without preoperative splenic artery embolisation
por: Zaitoun, Mohamed M. A., et al.
Publicado: (2018)

Single-cell RNA Sequencing Analysis Reveals New Immune Disorder Complexities in Hypersplenism
por: Zhao, Hai-chao, et al.
Publicado: (2022)

Investigation into imbalance of Th1/Th2 cells in cirrhotic, hypersplenic rats
por: Lv, Yunfu, et al.
Publicado: (2019)

Minimally invasive treatment of cirrhotic secondary hypersplenism with high-intensity focused ultrasound
por: Zhang, Xiumei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pdsal983hfekblha70oqdddglc